✦ LIBER ✦

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours

✍ Scribed by Michele Caraglia; Raffaele Addeo; Raffaele Costanzo; Liliana Montella; Vincenzo Faiola; Monica Marra; Alberto Abbruzzese; Giovannella Palmieri; Alfredo Budillon; Francesco Grillone; Salvatore Venuta; Pierosandro Tagliaferri; Salvatore Del Prete

Publisher: Springer
Year: 2005
Tongue: English
Weight: 216 KB
Volume: 57
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-005-0001-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of lonidamine plus radiot

Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases

✍ David J. Stewart; Libni Eapen; Andre Girard; Shailendra Verma; Paul Genest; Will 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 264 KB

Phase II study of liposomal annamycin in

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer

✍ Daniel J. Booser; Francisco J. Esteva; Edgardo Rivera; Vicente Valero; Laura Esp 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 56 KB

Phase I study of capecitabine in combina

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

✍ Edgardo Rivera; Christina Meyers; Morris Groves; Vicente Valero; Deborah Francis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors

✍ E. Claire Dees; Bert H. O’Neil; Celeste M. Lindley; Frances Collichio; Lisa A. C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 527 KB

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study

✍ Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Kos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB

Α multicenter phase II study of pegylate

Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer

✍ Nikolaos Xenidis; Nikolaos Vardakis; Ioannis Varthalitis; Stylianos Giassas; Emm 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 205 KB